Skip to main content
. 2010 Apr 30;29(11):1851–1864. doi: 10.1038/emboj.2010.77

Figure 3b.

Figure 3b

(B) BCBL-1 cells were either left untreated or were reactivated by treating with TPA (20 ng/ml) for 16 h, fixed and immunofluorescence staining performed using ORF57- and PYM-specific antibodies.